Lv1
98 积分 2024-07-23 加入
In vivo CAR T cells move into clinical trials
2小时前
待确认
Fabrication of active targeting lipid nanoparticles: Challenges and perspectives
18天前
已完结
In vivo chimeric antigen receptor (CAR)-T cell therapy
24天前
已完结
Reprogramming Exosomes as Nanoscale Controllers of Cellular Immunity
2个月前
已完结
Engineered exosome-mediated messenger RNA and single-chain variable fragment delivery for human chimeric antigen receptor T-cell engineering
2个月前
已完结
Direct cytosolic delivery of siRNA via cell membrane fusion using cholesterol-enriched exosomes
2个月前
已完结
Tumor-derived exosomes induce initial activation by exosomal CD19 antigen but impair the function of CD19-specific CAR T-cells via TGF-β signaling
3个月前
已完结
In Vivo CD19 CAR T-Cell Therapy for Refractory Systemic Lupus Erythematosus
3个月前
已完结
CD19-Targeted CAR T Cells in Refractory Systemic Lupus Erythematosus
3个月前
已完结
Hybrid Exosome–Liposome Nanoparticles for Dual Modulation of Neuroinflammation and Lipid Metabolism in Ischemic Stroke
4个月前
已完结
皖公网安备34019202002308
